For a long time, the only way to access the heart for a bypass operation was to sever the sternum (median sternotomy). Encouraged by the successes achieved by minimally-invasive surgery in other fields, cardiosurgery underwent rapid development, which eventually enabled thoracoscopic operations of the heart. Only with the development of complex robot systems and telesurgery, however, did it become possible to perform exclusively endoscopic bypass operations. Today, the heart-lung machine (HLM) is used as a standard device for bypass operations, with cardiac arrest induced by an infusion. Studies have shown that the HLM may lead to a significant inflammatory reaction and that it is advantageous, particularly for patients with bad cardiac function, to avoid cardiac arrest and keep the heart continuously supplied with blood. ‘Stabilisers’ have been developed to enable bypass operations on the beating heart without using an HLM. For operations on the beating heart using an exclusively endoscopic robot system, an endoscopic stabiliser has been developed, in cooperation with the Leipzig Cardiovascular Institute. The stabilisers that are already available are rigid and, hence, only suitable for an ‘open’ intervention, in conjunction with a retractor. Based on a flexible, superelastic unit made of NiTi, a stabiliser has now been developed that allows endoscopic insertion via a tube of 10 mm in diameter. Joint-like behaviour is achieved by the shaping of the NiTi wires and the specific removal of material in the curved areas. In the operating state, the stabiliser IS still rigid enough to immobilise the desired vascular section. The ENDOSTAB endoscopic stabiliser has already been successfully used in animal experiments at the Leipzig Cardiovascular Institute. The way is thus paved for exclusively endoscopic bypass operations on the beating heart without the use of an HLM.
Read full abstract